Familial-skewed X-chromosome inactivation as a predisposing factor for late-onset X-linked sideroblastic anemia in carrier females

被引:68
作者
Cazzola, M [1 ]
May, A
Bergamaschi, G
Cerani, P
Rosti, V
Bishop, DF
机构
[1] Policlin San Matteo, IRCCS, Div Hematol, I-27100 Pavia, Italy
[2] Univ Pavia, Sch Med, Dept Hematol, I-27100 Pavia, Italy
[3] Univ Pavia, Sch Med, Dept Internal Med & Med Therapy, I-27100 Pavia, Italy
[4] Cardiff Univ, Dept Haematol, Cardiff CF4 4XN, S Glam, Wales
[5] CUNY Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA
关键词
D O I
10.1182/blood.V96.13.4363.h8004363_4363_4365
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
X-linked sideroblastic anemia (XLSA) is caused by mutations in the erythroid-specific 5-aminolevulinic acid synthase (ALAS2) gene. An elderly woman who presented with an acquired sideroblastic anemia is studied. Molecular analysis revealed that she was heterozygous for a missense mutation in the ALAS2 gene, but she expressed only the mutated gene in reticulocytes. Her 2 daughters and a granddaughter were heterozygous for this mutation, had normal hemoglobin levels, and expressed the normal ALAS2 gene in reticulocytes. A grandson with a previous diagnosis of thalassemia intermedia was found to be hemizygous for the ALAS2 mutation. Treatment with pyridoxine completely corrected the anemia both in the proband and her grandson. All women who were analyzed in this family showed skewed X-chromosome inactivation in leukocytes, which indicated a hereditary condition associated with unbalanced lyonization. Because the preferentially active X chromosome carried the mutant ALAS2 allele, acquired skewing in the elderly likely worsened the genetic condition and abolished the normal ALAS2 allele expression in the proband. (Blood, 2000;96:4363-4365) (C) 2000 by The American Society of Hematology.
引用
收藏
页码:4363 / 4365
页数:3
相关论文
共 22 条
  • [1] ALVADO M, 1999, BLOOD S, V94, pA410
  • [2] Aruffo A, 1994, Curr Opin Hematol, V1, P12
  • [3] Hematologically important mutations: Glucose-6-phosphate dehydrogenase
    Beutler, E
    Vulliamy, T
    Luzzatto, L
    [J]. BLOOD CELLS MOLECULES AND DISEASES, 1996, 22 (04) : 49 - 56
  • [4] Busque L, 1996, BLOOD, V88, P59
  • [5] CAZZOLA M, 1985, HAEMATOLOGICA, V70, P291
  • [6] X-linked genetic factors regulate hematopoietic stem-cell kinetics in females
    Christensen, K
    Kristiansen, M
    Hagen-Larsen, H
    Skytthe, A
    Bathum, L
    Jeune, B
    Andersen-Ranberg, K
    Vaupel, JW
    Orstavik, KH
    [J]. BLOOD, 2000, 95 (07) : 2449 - 2451
  • [7] CONBOY JG, 1992, J BIOL CHEM, V267, P18753
  • [8] Four new mutations in the erythroid-specific 5-aminolevulinate synthase (ALAS2) gene causing X-linked sideroblastic anemia:: Increased pyridoxine responsiveness after removal of iron overload by phlebotomy and coinheritance of hereditary hemochromatosis
    Cotter, PD
    May, A
    Li, LP
    Al-Sabah, AI
    Fitzsimons, EJ
    Cazzola, M
    Bishop, DF
    [J]. BLOOD, 1999, 93 (05) : 1757 - 1769
  • [9] LATE-ONSET X-LINKED SIDEROBLASTIC ANEMIA
    COTTER, PD
    MAY, A
    FITZSIMONS, EJ
    HOUSTON, T
    WOODCOCK, BE
    ALSABAH, AI
    WONG, L
    BISHOP, DF
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (04) : 2090 - 2096
  • [10] El Kassar N, 1998, CLIN CHEM, V44, P61